Clinical trial · Interventional
Cognitive Rehabilitation Group Intervention for Breast Cancer Survivors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
There are over 2 million breast cancer survivors in the US today. Along with extended survival, many women experience short and long-term after effects of treatment, which may decrease their quality of life and contribute to other health problems. Cognitive complaints---difficulties with memory, concentration, and planning-are commonly reported after adjuvant treatments for breast cancer. This study is designed to test the efficacy of a 5 week group-based cognitive rehabilitation intervention on improving cognitive complaints and test performance, in comparison to women who will receive the same intervention at a later time (wait-list control). Women will also have an EEG test performed before and after the intervention program to see if improvements in cognitive complaints and performance can be documented by examining the EEG.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Improving Cognition with group intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Group Intervention program
- interventionNames
- Behavioral: Improving Cognition with group intervention
- type
- NO_INTERVENTION
- label
- Wait-list control group
- description
- The wait-list-control group will also be able to participate in the group intervention, but not until after all the study visits have been completed.
Primary outcomes (1)
- measure
- Cognitive function measured by neuropsychological assessment 2 months after group intervention
- timeFrame
- 2 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * age 21-65 years * stage I, II, III breast cancer diagnosis within the past 18 months to 5 years * currently disease free, but may be on endocrine therapy * with evidence of need of cognitive therapeutic intervention, as demonstrated by mild or greater cognitive deficiencies on an objective screening measure * reads and writes English * able to give informed consent * willing and able to attend 5 weekly group sessions and participate in pre and post-evaluation that will take place on the UCLA campus Exclusion Criteria: * evidence of uncontrolled depression
References
Publications (0)
Data not yet available